Bill Text: PA HB33 | 2009-2010 | Regular Session | Introduced


Bill Title: Requiring retailers of pharmaceutical drugs to have in place a system for the acceptance and collection of pharmaceutical drugs for proper disposal; and imposing civil penalties.

Spectrum: Moderate Partisan Bill (Democrat 18-5)

Status: (Introduced - Dead) 2009-01-26 - Referred to ENVIRONMENTAL RESOURCES AND ENERGY [HB33 Detail]

Download: Pennsylvania-2009-HB33-Introduced.html

  

 

    

PRINTER'S NO.  28

  

THE GENERAL ASSEMBLY OF PENNSYLVANIA

  

HOUSE BILL

 

No.

33

Session of

2009

  

  

INTRODUCED BY M. O'BRIEN, DePASQUALE, BEYER, JOSEPHS, MUNDY, DONATUCCI, HARKINS, McILVAINE SMITH, MELIO, PRESTON, SIPTROTH, K. SMITH, STURLA, HENNESSEY, GIBBONS AND WALKO, JANUARY 26, 2009

  

  

REFERRED TO COMMITTEE ON ENVIRONMENTAL RESOURCES AND ENERGY, JANUARY 26, 2009  

  

  

  

AN ACT

  

1

Requiring retailers of pharmaceutical drugs to have in place a

2

system for the acceptance and collection of pharmaceutical

3

drugs for proper disposal; and imposing civil penalties.

4

The General Assembly of the Commonwealth of Pennsylvania

5

hereby enacts as follows:

6

Section 1.  Short title.

7

This act shall be known and may be cited as the

8

Pharmaceutical Drug Disposal Act.

9

Section 2.  Statement of policy.

10

The General Assembly finds and declares as follows:

11

(1)  The United States Geological Survey conducted a

12

study in 2002 sampling 139 streams across 30 states and found

13

that 80% had measurable concentrations of prescription and

14

nonprescription drugs, steroids and reproductive hormones.

15

(2)  Exposure even to low levels of pharmaceuticals has

16

been shown to have negative effects on fish and other aquatic

17

species and may have negative effects on human health.

 


1

(3)  In order to reduce the likelihood of improper

2

disposal of pharmaceuticals, it is the purpose of this act to

3

establish a program that ensures the safe and environmentally

4

sound disposal of pharmaceutical drugs that is convenient for

5

consumers and cost effective for retailers.

6

Section 3.  Definitions.

7

The following words and phrases when used in this act shall

8

have the meanings given to them in this section unless the

9

context clearly indicates otherwise:

10

"Consumer."  An individual purchaser or owner of a

11

pharmaceutical drug. The term does not include a business,

12

corporation, limited partnership or any entity involved in a

13

wholesale transaction between a distributor and retailer.

14

"Department."  The Department of Environmental Protection of

15

the Commonwealth.

16

"Pharmaceutical drug."  A prescription or over-the-counter

17

drug, including, but not limited to, a drug as defined in

18

section 2 of the act of April 14, 1972 (P.L.233, No.64), known

19

as The Controlled Substance, Drug, Device and Cosmetic Act, or

20

section 201(g)(1) of the Federal Food, Drug, and Cosmetic Act

21

(52 Stat. 1040, 21 U.S.C. § 321(g)(1)).

22

"Retailer."  A person or entity that makes a retail sale of a

23

pharmaceutical drug to a consumer in this Commonwealth.

24

"Sale."  Includes, but is not limited to, transactions

25

conducted through sales outlets, catalogs or the Internet or any

26

other similar electronic means, but does not include a sale that

27

is a wholesale transaction involving a distributor or retailer.

28

Section 4.  Collection of pharmaceutical drugs.

29

(a)  General rule.--On or after July 1, 2009, each retailer

30

shall have in place a system for the acceptance and collection

- 2 -

 


1

of pharmaceutical drugs for proper disposal.

2

(b)  Elements.--A system for the acceptance and collection of

3

pharmaceutical drugs for proper disposal shall at a minimum

4

include the following elements:

5

(1)  The take back by the retailer at no cost to the

6

consumer of a pharmaceutical drug of the type or brand that

7

the retailer sells or previously sold.

8

(2)  A notice to consumers that includes informational

9

materials, including, but not limited to, Internet website

10

links or a telephone number, placed on the invoice or

11

purchase order or packaged with the pharmaceutical drug, that

12

provides consumers access to obtain more information about

13

the opportunities and locations for no-cost pharmaceutical

14

drug recycling.

15

(3)  Information made available to consumers about

16

pharmaceutical drug return opportunities provided by the

17

retailer and encouraging consumers to utilize those

18

opportunities. This information may include, but is not

19

limited to, the following:

20

(i)  Signage that is prominently displayed and easily

21

visible to the consumer.

22

(ii)  Written materials provided to the consumer at

23

the time of purchase or delivery, or both.

24

(iii)  Reference to the pharmaceutical drug take-back

25

opportunity in retailer advertising or other promotional

26

materials, or both.

27

(iv)  Direct communications with the consumer at the

28

time of purchase.

29

(c)  Alternative.--If a retailer participates in an existing

30

pharmaceutical drug take-back system and the system otherwise

- 3 -

 


1

complies with the requirements of this act, the retailer may

2

continue to participate in the existing program in lieu of

3

complying with the program under this act.

4

(d)  Regulations.--The department, in consultation with the

5

Department of Health, shall promulgate regulations that ensure

6

the proper disposal of pharmaceutical drugs, pursuant to all

7

applicable laws, and ensure the protection of public health and

8

safety, the environment and the health and safety of retail

9

employees.

10

(e)  Educational materials.--The department shall provide

11

educational materials to consumers informing them of the

12

availability of the pharmaceutical drug disposal program and

13

what constitutes proper and improper disposal of pharmaceutical

14

drugs.

15

Section 5.  Enforcement.

16

(a)  Violation.--On and after July 1, 2009, it is unlawful

17

for a retailer to sell a pharmaceutical drug to a consumer

18

unless the retailer complies with this act.

19

(b)  Penalty.--The Attorney General may bring an action for

20

injunctive relief, costs and attorney fees, and a civil penalty

21

the court may impose on a retailer that fails to comply with the

22

requirements of this act a civil penalty of no more than $10,000

23

per violation. Each unlawful failure to provide for

24

pharmaceutical drug disposal shall constitute a separate

25

violation.

26

Section 6.  Effective date.

27

This act shall take effect immediately.

- 4 -

 


feedback